BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
1.990
+0.060 (3.11%)
Dec 5, 2025, 4:00 PM EST - Market closed
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $81.83 million as of December 5, 2025. Its market cap has increased by 18.09% in one year.
Market Cap
81.83M
Enterprise Value
69.62M
1-Year Change
18.09%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $81.83M, a decrease of -77.40%. That is a compound annual growth rate of -15.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 80.30M | 22.22% |
| Dec 31, 2024 | 65.70M | 87.18% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |